FINWIRES · TerminalLIVE
FINWIRES

Sun Pharmaceutical Industries Consolidated Profit Grows in Fiscal Q4; Shares Slip 3

By

Sun Pharmaceutical Industries' (NSE:SUNPHARMA, BOM:524715) consolidated net profit increased to 27.1 billion Indian rupees in the fiscal fourth quarter ended March 31, from 21.5 billion rupees a year ago.

Earnings per share climbed to 11.3 rupees from the year-ago figure of 9.0 rupees, according to a Friday filing to the Indian stock exchanges by the pharmaceutical company.

Total revenue from operations in fiscal Q4 jumped to 146.1 billion rupees from 129.6 billion rupees a year earlier.

The company's board declared a final dividend of 5 rupees per share for the financial year ended March 31.

Sun Pharma's shares were down nearly 3% in recent trade.

Related Articles

Asia

China Power International Sells 2 Billion Yuan Bond

China Power International Development (HKG:2380) issued 2 billion yuan of three-year bonds carrying a coupon rate of 1.63% per annum.The electric power company will use proceeds to repay a maturing debt, according to a Friday filing with the Hong Kong bourse.

$HKG:2380
Asia

Hongkong Land Buys Back More Shares

Hongkong Land (SGX:H78) bought back 78,300 shares on Thursday at a weighted average price of $7.99 apiece, according to a Friday Singapore bourse filing.The repurchased shares will be canceled, the real estate developer said.

$SGX:H78
Asia

Jarden Adjusts Mineral Resources' Price Target to AU$27 from AU$22.50, Keeps at Sell

Mineral Resources (ASX:MIN) has an average rating of overweight and mean price target of AU$67.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ASX:MIN